Make in India for Pharma: Why Domestic API Manufacturing Matters for Global Healthcare
A supply chain is only as reliable as its most fragile link, and for years, that link was India's dependence on imported chemicals to make its own medicines. This article digs into why that's finally changing and why building API capacity at home has become more than just an economic goal. It's a national priority. From the Aatmanirbhar Bharat initiative to the incentives behind the PLI scheme, the piece traces how India is working to close the gap between raw key starting materials and the finished APIs that go into life-saving drugs and what that means for the stability of medicine supplies worldwide.
Read the full article: Domestic API manufacturing









